Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0418 Advanced Prostate 4/1/2005 5/1/2006 62% Published
    Closed S0414 ESOPHAGEAL 5/1/2005 9/1/2007 29% Published
    Closed S0508 Thalidomide + Temozolomide in Metastatic Melanoma 6/1/2005 1/1/2007 100% Published
    Closed S0515 NON-HODGKIN'S: R-CHOP + Bevacizumab for Adv Stage Diffuse Large B-cell NHL 6/15/2005 9/15/2008 100% Published
    Closed S0435 BAY 43-9006 in Platinum-Treated Extensive SCLC 7/1/2005 2/15/2007 100% Published
    Closed S0430 ADVANCED: Simple Oral Therapy for Metastic Breast Cancer 8/15/2005 9/1/2007 100% Published
    Closed S0350 NON-HODGKIN: PEGS treatment for Peripheral T-Cell NHL 9/15/2005 12/1/2010 100% Published
    Closed S0517 HODGKIN'S: SAHA for Recurrent or Primary Refractory Hodgkin's Lymphoma 9/15/2005 8/1/2007 77% Published
    Closed S0514 GALLBLADDER AND CHOLANGIOCARCINOMA 10/1/2005 1/1/2007 72% Published
    Closed S0429 Docetaxel and Cetuximab Chemoradiation in Stage III NSCLC 4/1/2006 8/15/2009 40% Published
    Closed S0433 NON-HODGKIN: R-CHOP + Bexxar for Advanced Stage Diffuse Large B-Cell Lymphoma 11/1/2005 100% Published
    Closed S0509 AZD2171/Malignant Pleural Mesothelioma 11/1/2005 4/1/2008 100% Published
    Closed S0438 BAY 43-9006 + CCI-779 or R115777 in Metastatic Melanoma 8/1/2007 11/15/2009 91% Published
    Closed S0520 NON-HODGKIN: PXD101 Therapy for B-Cell Lymphoma 1/1/2006 5/1/2009 55% Published
    Closed S0505 Soft Tissue Sarcomas 3/1/2006 68% Published
    Closed S0434 Phase II Relapsing/Resistant Myeloma Previously Treated with Bortezomib 3/15/2006 58% Published
    Closed S0512 BAY 43-9006 in Combination with Carboplatin + Paclitaxel in Metastatic Uveal Melanoma 3/15/2006 1/1/2009 56% Published
    Closed S0618 Recurrent or Metastatic Squamous Cell 5/1/2006 1/1/2008 95% Published
    Closed S0605 Phase II Revlimid Untreated Non-M3, 5q- AML and >= Age 60 6/15/2006 7/1/2010 91% Published
    Closed S0533 Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC 6/15/2006 3/1/2010 16% Published
    Scroll Table